{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:04:23Z","timestamp":1776395063979,"version":"3.51.2"},"reference-count":40,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1210\/jc.2012-4003","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T05:26:10Z","timestamp":1362547570000},"page":"1718-1725","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacodynamics of Cinacalcet Over 48 Hours in Patients With Controlled Secondary Hyperparathyroidism: Useful Data in Clinical Practice"],"prefix":"10.1210","volume":"98","author":[{"given":"M. Dolores","family":"Arenas","sequence":"first","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"de la Fuente","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Delgado","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Teresa","family":"Gil","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Ribero","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Nephrology Service (M.R.), Hospital Reina Sof\u00eda, ES-14004 C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Almad\u00e9n","sequence":"additional","affiliation":[{"name":"Lipid and Atherosclerosis Unit (Y.A.), IMIBIC\/Reina Sofia University Hospital\/University of Cordoba, and Centro de Investigaci\u00f3n Biom\u00e9dica en Red Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, ES-28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113333040200_B1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.HYP.0000219635.51844.da","article-title":"Calcification and cardiovascular health: new insights into an old phenomenon","volume":"47","author":"Ketteler","year":"2006","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113333040200_B2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041113333040200_B3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041113333040200_B4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2215\/CJN.01060308","article-title":"Consistent control of mineral and bone disorder in incident hemodialysis patients","volume":"3","author":"Danese","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B5","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B6","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113333040200_B7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/ENDO:10:2:97","article-title":"The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism","volume":"10","author":"Fox","year":"1999","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t2019041113333040200_B8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ki.2008.642","article-title":"Phosphate and the parathyroid","volume":"75","author":"Silver","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113333040200_B10","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfn026","article-title":"Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism","volume":"23","author":"Block","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019041113333040200_B11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2215\/CJN.00870805","article-title":"Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate","volume":"1","author":"Chertow","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B14","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B15","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B17","volume-title":"Principles of bone biology","author":"Bilezikian","year":"2008"},{"key":"key\n\t\t\t\t2019041113333040200_B18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B19","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019041113333040200_B20","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/ndt\/gfq307","article-title":"Effects of cinacalcet on vascular calcification in haemodialysis patients","volume":"25","author":"Almirall","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019041113333040200_B21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ki.2010.167","article-title":"Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients","volume":"78","author":"Block","year":"2010","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1523-1755.1998.00735.x","article-title":"A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication","volume":"53","author":"Antonsen","year":"1998","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.110.178681","article-title":"Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion","volume":"337","author":"Henley","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041113333040200_B24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1542-4758.2006.01171.x","article-title":"Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study","volume":"10","author":"Roueff","year":"2006","journal-title":"Hemodial Int"},{"key":"key\n\t\t\t\t2019041113333040200_B25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000304180","article-title":"Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"31","author":"Borchhardt","year":"2010","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B26","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t2019041113333040200_B27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.jrn.2006.04.010","article-title":"Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease","volume":"16","author":"Ure\u00f1a Torres","year":"2006","journal-title":"J Ren Nutr"},{"key":"key\n\t\t\t\t2019041113333040200_B28","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00261950?term=bonafide&rank=1 . 2012. Accessed February 22, 2013."},{"key":"key\n\t\t\t\t2019041113333040200_B29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041113333040200_B30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019041113333040200_B32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/dmd.104.000604","article-title":"Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models","volume":"32","author":"Kumar","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019041113333040200_B33","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113333040200_B34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t2019041113333040200_B35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0030-1248255","article-title":"Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling","volume":"42","author":"de Paula","year":"2010","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113333040200_B36","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/gfm156","article-title":"Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy","volume":"22","author":"Lomonte","year":"2007","journal-title":"Nephrol Dialysis Transplant"},{"key":"key\n\t\t\t\t2019041113333040200_B37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019041113333040200_B38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00198-010-1262-x","article-title":"Reduction of whole PTH\/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism","volume":"22","author":"Kurajoh","year":"2010","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113333040200_B39","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113333040200_B40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10157-010-0264-5","article-title":"Amino terminal cleavage of PTH(1\u201384) to PTH(7\u201384) is regulated by serum calcium concentration via calcium-sensing receptor in hemodialysis patients","volume":"14","author":"Koshikawa","year":"2010","journal-title":"Clin Exp Nephrol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/4\/1718\/9048524\/jcem1718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T05:54:17Z","timestamp":1644472457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/4\/1718\/2537045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-4003","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}